CCF: Cleveland Clinic Foundation; ECOG PS: Eastern Cooperative Oncology Group Performance Score; IKCWG: International Kidney Cancer Working ... disease with a short life expectancy.

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...

Key TakeawaysKidney transplant recipients who’ve never been exposed to the Epstein-Barr virus but receive organs from a donor ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center ...

Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center ...

No recurrence after 4 years? Here's all you need to know about the kidney cancer vaccine that could change everything New vaccine wipes out kidney cancer recurrence: Is this the future of oncology?( ...

More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious ...

Kidney transplant patients who've never been exposed to EBV but receive organs from a donor who carried the virus may develop a life-threatening ... control and act like cancer.